Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(31 sites)
United States
Clinical Site, Phoenix, Arizona Clinical Site, Scottsdale, Arizona Clinical Site, Irvine, California Clinical Site, Loma Linda, California Clinical Site, Altamonte Springs, Florida Clinical Site, Boca Raton, Florida Clinical Site, Coral Springs, Florida Clinical Site, Hallandale, Florida Clinical Site, Maitland, Florida Clinical Site, Miami, Florida Clinical Site, Ocala, Florida Clinical Site, Orlando, Florida Clinical Site, Orlando, Florida Clinical Site, Port Orange, Florida Clinical Site, Tampa, Florida Clinical Site, Augusta, Georgia Clinical Site, Decatur, Georgia Clinical Site, Kansas City, Kansas Clinical Site, Farmington Hills, Michigan Clinical Site, Golden Valley, Minnesota Clinical Site, Albany, New York Clinical Site, Rock Hill, South Carolina Clinical Site, Memphis, Tennessee Clinical Site, Austin, Texas Clinical Site, Dallas, Texas Clinical Site, Georgetown, Texas Clinical Site, Falls Church, Virginia Clinical Site, Henrico, Virginia Clinical Site, Kirkland, Washington Clinical Site, Spokane, Washington Clinical Site, Milwaukee, Wisconsin Last updated October 2024